The Lysophospholipid Acyltransferase Antagonist CI-976 Inhibits a Late Step in COPII Vesicle Budding
Article first published online: 30 JAN 2008
DOI: 10.1111/j.1600-0854.2008.00711.x
© 2008 The Authors
Additional Information
How to Cite
Brown, W. J., Plutner, H., Drecktrah, D., Judson, B. L. and Balch, W. E. (2008), The Lysophospholipid Acyltransferase Antagonist CI-976 Inhibits a Late Step in COPII Vesicle Budding. Traffic, 9: 786–797. doi: 10.1111/j.1600-0854.2008.00711.x
Publication History
- Issue published online: 30 JAN 2008
- Article first published online: 30 JAN 2008
- Received 9 August 2007, revised and accepted for publication 23 January 2008, uncorrected manuscript published online 30 January 2008, published online 4 March 2008
- Abstract
- Article
- References
- Cited By
Keywords:
- COPII vesicles;
- ER exit sites;
- lysophospholipid acyltransferase;
- membrane curvature;
- vesicle fission
The mechanism of coat protein (COP)II vesicle fission from the endoplasmic reticulum (ER) remains unclear. Lysophospholipid acyltransferases (LPATs) catalyze the conversion of various lysophospholipids to phospholipids, a process that can promote spontaneous changes in membrane curvature. Here, we show that 2,2-methyl-N-(2,4,6,-trimethoxyphenyl)dodecanamide (CI-976), a potent LPAT inhibitor, reversibly inhibited export from the ER in vivo and the formation of COPII vesicles in vitro. Moreover, CI-976 caused the rapid and reversible accumulation of cargo at ER exit sites (ERESs) containing the COPII coat components Sec23/24 and Sec13/31 and a marked enhancement of Sar1p-mediated tubule formation from ERESs, suggesting that CI-976 inhibits the fission of assembled COPII budding elements. These results identify a small molecule inhibitor of a very late step in COPII vesicle formation, consistent with fission inhibition, and demonstrate that this step is likely facilitated by an ER-associated LPAT.

1600-0854/asset/TRA_bg_left.gif?v=1&s=5889c23a45bcc9ffc5deaa3d9b2e1cb8329459e7)
1600-0854/asset/TRA_centre.gif?v=1&s=e30b572cf41f5940b7b3ec55f0b42884cec3f888)
